OTC · Biotechnology

GlobeStar Therapeutics Corporation (GSTC) Stock

$0.00 OTC: GSTC Healthcare

GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders.

Valuation

MetricValue
Price$0.00
Market Cap$124111
P/E Ratio-0.04
P/B Ratio-0.06
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE200.00%
ROA0.00%
ROCE130.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.05

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$0$0$-9.0M$-1.0M$-2.0M
Net Profit$-1.0M$-1.0M$-10.0M$-1.0M$-2.0M
EPS$-0.02$0.00$-0.02$0.00$0.00
Op Margin-74352.9%-394805.2%———

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$0$0$0$0$0
Total Liabilities$1.0M$1.0M$1.0M$1.0M$1.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$0$-1.0M$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$-1.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA72.89
FCF Yield-165.79%
Quick Ratio0.00
Interest Coverage-20.35
Return 1Y0.00%
Return 3Y-96.87%
Return 5Y-99.74%

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Ancora Advisors, LLC88,0002024-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACUSAcusphere, Inc. $0.00 — 0.00 $49 0.00%
AMPEAmpio Pharmaceuticals, Inc. $0.18 +0.00% -0.02 $207884 0.00%
BIOAFBioasis Technologies Inc. $0.00 — -0.12 $7941 0.00%
EHOSEhouse Global, Inc. $0.00 — 0.00 $10127 0.00%
GBLXGB Sciences, Inc. $0.00 — -0.07 $122121 0.00%

About GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.

GlobeStar Therapeutics Corporation (GSTC) stock trades at $0.00 with a market capitalization of $124111. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of -0.06, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, GlobeStar Therapeutics Corporation generates a return on equity (ROE) of 200.00% — well above the market average, a sign of a high-quality business, return on capital employed of 130.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.globestartherapeutics.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides